Abcam (LON:ABC)‘s stock had its “hold” rating reissued by stock analysts at Peel Hunt in a research report issued to clients and investors on Thursday.

Separately, Numis Securities reiterated a “hold” rating on shares of Abcam in a report on Tuesday, September 11th.

Abcam stock opened at GBX 1,062 ($13.88) on Thursday. Abcam has a 1-year low of GBX 9.73 ($0.13) and a 1-year high of GBX 1,290 ($16.86).

In related news, insider Jonathan Simon Milner sold 1,000,000 shares of the stock in a transaction dated Friday, September 28th. The shares were sold at an average price of GBX 1,441 ($18.83), for a total value of £14,410,000 ($18,829,217.30). Also, insider Suzanne Smith purchased 864 shares of the firm’s stock in a transaction that occurred on Wednesday, November 7th. The stock was bought at an average cost of GBX 1,219 ($15.93) per share, with a total value of £10,532.16 ($13,762.13).

Abcam Company Profile

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

Read More: Why is the Consumer Price Index (CPI) important?

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.